e-learning
resources
Virtual 2021
07.09.2021
Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Follicular T helper and Breg cell balance in severe allergic asthma before and after omalizumab therapy
L. Bergantini (siena, Italy), M. D'Alessandro (siena, Italy), P. Cameli (siena, Italy), B. Cekorja (siena, Italy), E. Bargagli (siena, Italy)
Source:
Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD
Session:
Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD
Session type:
Oral Presentation
Number:
2831
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Bergantini (siena, Italy), M. D'Alessandro (siena, Italy), P. Cameli (siena, Italy), B. Cekorja (siena, Italy), E. Bargagli (siena, Italy). Follicular T helper and Breg cell balance in severe allergic asthma before and after omalizumab therapy. 2831
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Chemokine-receptor expression on allergen-specific T cells in allergic asthma and allergic bronchopulmonary aspergillosis
Source: Eur Respir J 2007; 30: Suppl. 51, 372s
Year: 2007
Cytokine production profile of T-lymphocytes and frequence of regulatory T-cells in patients with allergic asthma receiving anti-IgE therapy
Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E
Year: 2011
Expression of surface markers on peripheral CD4
+
CD25
high
T cells in patients with atopic asthma: role of inhaled corticosteroid
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008
Gamma/delta T cells regulate airways disease during rhinovirus-induced asthma exacerbations
Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections
Year: 2011
T cell cytokine profiles in childhood asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 391s
Year: 2002
CD39/CD73 and the imbalance of Th17 and Tregs (regulatory T cells) in allergic asthma
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013
Study of the effect of IL-4 and IFN-γ on Th1/Th2 cells and mast cells in allergic asthma patients
Source: Eur Respir J 2001; 18: Suppl. 33, 271s
Year: 2001
Steroid insensitivity of airway T lymphocytes in COPD patients
Source: Annual Congress 2009 - Pathology and immunology of COPD
Year: 2009
Type-2 CD8+ T lymphocytes responsive to PGD2/LTE4 in severe eosinophilic asthma
Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases
Year: 2018
Omalizumab enhances the percentage of GARP cells in both regulatory and terminally differentiated effector Th cells in severe allergic asthmatics
Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD
Year: 2018
IL-10-producing CD4
+
T cells are essential for the development of airway hyperresponsiveness
Source: Annual Congress 2004 - Modulation of the allergic response in animal models
Year: 2004
Increased T helper lymphocytes and macrophages in peripheral airways of patients with uncontrolled asthma
Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation
Year: 2010
T Lymphocyte clonal expansion in response to
Staphylococcus aureus
airway colonization in severe asthma
Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Year: 2010
Regulatory T-lymphocytes in asthma
Source: Eur Respir J 2005; 26: 918-932
Year: 2005
The impact of sublingual immunotherapy (SLIT) of asthma on Th1 cells susceptibility to apoptosis
Source: Annual Congress 2012 - Predicting and observing paediatric allergic disease
Year: 2012
Features of functioning of T cell regulatory subpopulations in acute bronchial asthma
Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Year: 2009
T-cell co-stimulatory molecules: their role in allergic immune reactions
Source: Eur Respir J 2007; 29: 1246-1255
Year: 2007
Reduced numbers of circulating CD4
+
CD25
high
FOXP3
+
regulatory T cells in patients with allergic asthma
Source: Annual Congress 2008 - Understanding airway inflammation
Year: 2008
Induction of regulatory T cell by 1,25-dihydroxyvitamin D3-treared dendritic cell attribute to the prevention of allergic airway inflammation
Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept